W. Y. Ding Et Al. , "Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry," EUROPACE , vol.24, no.5, pp.721-728, 2022
Ding, W. Y. Et Al. 2022. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry. EUROPACE , vol.24, no.5 , 721-728.
Ding, W. Y., Proietti, M., Boriani, G., Fauchier, L., Blomstrom-Lundqvist, C., Marin, F., ... Potpara, T. S.(2022). Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry. EUROPACE , vol.24, no.5, 721-728.
Ding, Wern Et Al. "Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry," EUROPACE , vol.24, no.5, 721-728, 2022
Ding, Wern Y. Et Al. "Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry." EUROPACE , vol.24, no.5, pp.721-728, 2022
Ding, W. Y. Et Al. (2022) . "Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry." EUROPACE , vol.24, no.5, pp.721-728.
@article{article, author={Wern Yew Ding Et Al. }, title={Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry}, journal={EUROPACE}, year=2022, pages={721-728} }